Terms: = Head and neck cancer AND ETV6, TEL/ABL, 2120, ENSG00000139083, P41212, TEL AND Treatment
47 results:
1. Macrofollicular Architecture in Invasive Encapsulated Follicular Variant of Papillary Thyroid Carcinoma: A Pitfall in Thyroid Practice.
Yadav S; Kandasamy D; Damle N; Goel R; Chumber S; Sharma MC; Boruah M; Agarwal S
Head Neck Pathol; 2023 Dec; 17(4):899-909. PubMed ID: 37775618
[TBL] [Abstract] [Full Text] [Related]
2. Secretory carcinoma of salivary glands with NTRK3 break-apart molecular rearrangement: Potential misdiagnosis with mucoepidermoid carcinoma.
Nocini R; Sanna G; Trotolo A; Fior A; Brunelli M; Manfrin E; Favero V
J Stomatol Oral Maxillofac Surg; 2023 Dec; 124(6S):101635. PubMed ID: 37709146
[TBL] [Abstract] [Full Text] [Related]
3. Precision oncology using organoids of a secretory carcinoma of the salivary gland treated with TRK-inhibitors.
Lassche G; van Engen-van Grunsven ACH; van Hooij O; Aalders TW; Am Weijers J; Cocco E; Drilon A; Hoischen A; Neveling K; Schalken JA; Verhaegh GW; van Herpen CML
Oral Oncol; 2023 Feb; 137():106297. PubMed ID: 36610231
[TBL] [Abstract] [Full Text] [Related]
4. TRK Inhibition with Entrectinib in Metastatic Salivary Secretory Carcinoma (SC): A Case Report.
Ernst MS; Lysack JT; Hyrcza MD; Chandarana SP; Hao D
Curr Oncol; 2022 May; 29(6):3933-3939. PubMed ID: 35735423
[TBL] [Abstract] [Full Text] [Related]
5. Clinicopathological investigation of secretory carcinoma cases including a successful treatment outcome using entrectinib for high-grade transformation: a case report.
Suzuki K; Harada H; Takeda M; Ohe C; Uemura Y; Kawahara A; Sawada S; Kanda A; Sengupta B; Iwai H
BMC Med Genomics; 2022 Jan; 15(1):6. PubMed ID: 34991563
[TBL] [Abstract] [Full Text] [Related]
6. Secretory Carcinoma in Children and Young Adults: A Case Series.
Simon CT; McHugh JB; Rabah R; Heider A
Pediatr Dev Pathol; 2022; 25(2):155-161. PubMed ID: 34606389
[TBL] [Abstract] [Full Text] [Related]
7. [Secretory carcinoma of salivary gland: a clinicopathological and prognostic analysis of twelve cases].
Cao YS; Lyu XQ
Zhonghua Bing Li Xue Za Zhi; 2021 Aug; 50(8):899-903. PubMed ID: 34344073
[No Abstract] [Full Text] [Related]
8. Diagnostic challenges and successful organ-preserving therapy in a case of secretory carcinoma of minor salivary glands.
Bill R; Deschler DG; Pittet MJ; Pai SI; Sadow PM; Park JC
Cancer Rep (Hoboken); 2022 Mar; 5(3):e1491. PubMed ID: 34231337
[TBL] [Abstract] [Full Text] [Related]
9. Secretory carcinoma of salivary gland origin: A recently established masquerader.
Budhiraja S; Kumar R; Khanna G; Sagar P; Arava S; Barwad A; Mridha AR
Indian J Cancer; 2021; 58(2):278-284. PubMed ID: 34100414
[TBL] [Abstract] [Full Text] [Related]
10. Targeted DNA profiling and the prevalence of NTRK aberrations in Chinese patients with head and neck cancer.
Xu J; Wang R; Wang T; Wang T; Gu D; He Y; Shu Y; Chen R; Liu L
Oral Oncol; 2021 Aug; 119():105369. PubMed ID: 34098386
[TBL] [Abstract] [Full Text] [Related]
11. Clinical Activity of Selitrectinib in a Patient With Mammary Analogue Secretory Carcinoma of the Parotid Gland With Secondary Resistance to Entrectinib.
Florou V; Nevala-Plagemann C; Whisenant J; Maeda P; Gilcrease GW; Garrido-Laguna I
J Natl Compr Canc Netw; 2021 May; 19(5):478-482. PubMed ID: 34030125
[TBL] [Abstract] [Full Text] [Related]
12. Surgically Treated Advanced Cutaneous Squamous Cell Carcinoma of the head and neck: Outcome Predictors and the Role of Adjuvant Radiation Therapy.
Kampel L; Dorman A; Horowitz G; Fliss DM; Gutfeld O; Muhanna N
Ann Otol Rhinol Laryngol; 2021 Sep; 130(9):1016-1023. PubMed ID: 33514267
[TBL] [Abstract] [Full Text] [Related]
13. Mammary analog secretory carcinoma of the thyroid gland: A rare cancer harboring TRK fusion.
Huang NS; Cao YM; Lu ZW; Guan Q; Chen JY; Ma B; Chen TZ; Bai QM; Wang YL; Ji QH
Oral Oncol; 2021 Apr; 115():105092. PubMed ID: 33189578
[TBL] [Abstract] [Full Text] [Related]
14. [Sinonasal renal cell-like adenocarcinoma: a clinicopathological analysis of five cases].
Yuan CC; Zhai CW; Wang SY
Zhonghua Bing Li Xue Za Zhi; 2020 Nov; 49(11):1147-1151. PubMed ID: 33152820
[No Abstract] [Full Text] [Related]
15. Characterization of novel genetic alterations in salivary gland secretory carcinoma.
Na K; Hernandez-Prera JC; Lim JY; Woo HY; Yoon SO
Mod Pathol; 2020 Apr; 33(4):541-550. PubMed ID: 31822803
[TBL] [Abstract] [Full Text] [Related]
16. Rapid, complete and sustained tumour response to the TRK inhibitor larotrectinib in an infant with recurrent, chemotherapy-refractory infantile fibrosarcoma carrying the characteristic etv6-NTRK3 gene fusion.
Bielack SS; Cox MC; Nathrath M; Apel K; Blattmann C; Holl T; Jenewein R; Klenk U; Klothaki P; Müller-Abt P; Ortega-Lawerenz S; Reynolds M; Scheer M; Simon-Klingenstein K; Stegmaier S; Tupper R; Vokuhl C; von Kalle T
Ann Oncol; 2019 Nov; 30(Suppl_8):viii31-viii35. PubMed ID: 31738425
[TBL] [Abstract] [Full Text] [Related]
17. Concurrent Identification of Novel EGFR-SEPT14 Fusion and etv6-RET Fusion in Secretory Carcinoma of the Salivary Gland.
Black M; Liu CZ; Onozato M; Iafrate AJ; Darvishian F; Jour G; Cotzia P
Head Neck Pathol; 2020 Sep; 14(3):817-821. PubMed ID: 31502214
[TBL] [Abstract] [Full Text] [Related]
18. Clinical characteristics of acinic cell carcinoma and secretory carcinoma of the parotid gland.
Terada T; Kawata R; Noro K; Higashino M; Nishikawa S; Haginomori SI; Kurisu Y; Kuwabara H; Hirose Y
Eur Arch Otorhinolaryngol; 2019 Dec; 276(12):3461-3466. PubMed ID: 31440815
[TBL] [Abstract] [Full Text] [Related]
19. A Case of Papillary Thyroid Carcinoma and Kostmann Syndrome: A Genomic Theranostic Approach for Comprehensive treatment.
Han S; Ehrhardt J; Shukla S; Elkbuli A; Nikiforov YE; Gulec SA
Am J Case Rep; 2019 Jul; 20():1027-1034. PubMed ID: 31308356
[TBL] [Abstract] [Full Text] [Related]
20. Relationship between genetic alterations and clinicopathological characteristics of papillary thyroid carcinoma.
Kure S; Wada R; Naito Z
Med Mol Morphol; 2019 Dec; 52(4):181-186. PubMed ID: 30788603
[TBL] [Abstract] [Full Text] [Related]
[Next]